Composition of Trypsin-Chymotrypsin (Chymoral Forte)
Chymoral Forte contains trypsin and chymotrypsin as its active proteolytic enzymes, typically formulated as trypsin-chymotrypsin in a fixed-dose combination tablet.
Active Ingredients
The standard formulation of Chymoral Forte contains:
- Trypsin - a proteolytic enzyme derived from pancreatic tissue
- Chymotrypsin - a proteolytic enzyme also derived from pancreatic tissue
These are pancreatic proteases that work synergistically to provide anti-inflammatory and tissue repair effects 1, 2, 3, 4.
Clinical Context and Mechanism
The trypsin-chymotrypsin combination functions as an oral proteolytic enzyme preparation that has been in clinical use since the 1960s 4. These enzymes work by:
- Degrading damaged cells and necrotic material during the inflammatory phase of wound healing
- Inactivating inflammatory mediators and toxic products to restrict edema and pain
- Modulating acute-phase proteins including C-reactive protein, alpha-1-antitrypsin, and alpha-2-macroglobulin 2
- Regulating cytokine levels, particularly IL-1β and IL-6, which helps control the severity of the inflammatory phase 5
Comparative Formulations
It's important to note that while Chymoral Forte specifically contains trypsin-chymotrypsin, other enzyme preparations exist with different compositions:
- Some formulations combine trypsin with bromelain and rutoside instead of chymotrypsin 6, 3
- These alternative combinations have shown comparable but not superior efficacy to trypsin-chymotrypsin 3
Clinical Applications
The trypsin-chymotrypsin combination has demonstrated efficacy in:
- Post-surgical wound healing (orthopedic and general surgery) 3, 4
- Acute inflammatory conditions including hemorrhoids 1
- Burn injury management 2, 5
- Resolution of edema, erythema, and pain associated with tissue injury 3, 4
The preparation provides better resolution of inflammatory symptoms and promotes speedier recovery of acute tissue injury compared to several other existing enzyme preparations 4.